Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific allegations of misleading statements and undisclosed risks impacting their business operations and prospects [1]. Company Summaries PayPal Holdings, Inc. (NASDAQ: PYPL) - Class Period: February 25, 2025 – February 2, 2026 - Allegations include overstating business execution capabilities, ineffective Branded Checkout initiatives, and dismissing competition concerns, leading to materially misleading statements about the company's operations and prospects [2]. NuScale Power Corporation (NYSE: SMR) - Class Period: May 13, 2025 – November 6, 2025 - Allegations state that the company misrepresented its partnership with ENTRA1, which lacked experience in nuclear power projects, exposing its commercialization strategy to undisclosed risks and leading to misleading statements about its business and prospects [3]. Corcept Therapeutics Incorporated (NASDAQ: CORT) - Class Period: October 31, 2024 – December 30, 2025 - Allegations include failure to disclose FDA concerns regarding the adequacy of the relacorilant effectiveness assessment program, which could lead to significant issues during the NDA review, resulting in misleading statements about the company's operations and prospects [4]. Navan, Inc. (NASDAQ: NAVN) - Class Period: October 2025 IPO - Allegations indicate that the company increased its sales and marketing expenses by 39% ($95 million) to sustain revenue growth, which was not disclosed, leading to misleading statements about the company's business and prospects [5].

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1][2]. Oracle Corporation (NYSE: ORCL) - Class period is from June 12, 2025, to December 16, 2025, with a lead plaintiff deadline of April 6, 2026 [2]. - Allegations include misleading statements regarding Oracle's AI infrastructure strategy, which is expected to lead to significant increases in capital expenditures without corresponding near-term revenue growth [3]. - Concerns raised about increased spending affecting Oracle's debt, credit rating, free cash flow, and project funding capabilities [3]. Paysafe Limited (NYSE: PSFE) - Class period is from March 4, 2025, to November 12, 2025, with a lead plaintiff deadline of April 7, 2026 [4]. - Allegations include significant exposure to a high-risk client in its e-commerce business, leading to understated credit loss reserves and write-offs [4]. - Issues with higher risk Merchant Category Codes are said to complicate client services, potentially impacting revenue growth and financial guidance for fiscal year 2025 [4]. Inovio Pharmaceuticals, Inc. (NASDAQ: INO) - Class period is from October 10, 2023, to December 26, 2025, with a lead plaintiff deadline of April 7, 2026 [5]. - Allegations include deficiencies in manufacturing for Inovio's CELLECTRA device, affecting the submission of the INO-3107 Biologics License Application (BLA) to the FDA [5]. - Concerns about overstated regulatory and commercial prospects for INO-3107 due to insufficient information for FDA approval [5]. Kyndryl Holdings, Inc. (NYSE: KD) - Class period is from August 7, 2024, to February 9, 2026, with a lead plaintiff deadline of April 13, 2026 [6]. - Allegations include materially misstated financial statements and inadequate internal controls, which may delay the filing of the Quarterly Report for the quarter ended December 31, 2025 [6]. - Positive statements about Kyndryl's business and operations are claimed to be materially misleading [6].

Core Viewpoint - Class action lawsuits have been filed against several publicly-traded companies, alleging misleading statements and failures to disclose critical information that affected shareholders during specified class periods [1]. Group 1: Freeport-McMoRan Inc. (NYSE: FCX) - The class period for Freeport-McMoRan is from February 15, 2022, to September 24, 2025, with a lead plaintiff deadline of January 12, 2026 [2]. - Allegations include failure to ensure safety at the Grasberg Block Cave mine, leading to heightened risks for workers and potential regulatory and reputational consequences [2]. Group 2: Perrigo Company plc (NYSE: PRGO) - The class period for Perrigo is from February 27, 2023, to November 4, 2025, with a lead plaintiff deadline of January 16, 2026 [3]. - The complaint claims significant underinvestment in the infant formula business acquired from Nestlé, requiring substantial capital expenditures beyond stated estimates, resulting in overstated financial results [3]. Group 3: StubHub Holdings, Inc. (NYSE: STUB) - The class period for StubHub is from its September 2025 IPO, with a lead plaintiff deadline of January 23, 2026 [4]. - Allegations include misleading statements regarding changes in vendor payment timing, adversely affecting free cash flow and misrepresenting the company's financial health [4]. Group 4: Alexandria Real Estate Equities, Inc. (NYSE: ARE) - The class period for Alexandria is from January 27, 2025, to October 27, 2025, with a lead plaintiff deadline of January 26, 2026 [5]. - The complaint alleges that the company overstated the value of its life-science properties and downplayed declining occupancy stability, leading to materially misleading statements about its business prospects [5].

Core Points - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1][2][3][4]. Group 1: Freeport-McMoran Inc. (NYSE: FCX) - The class period for Freeport-McMoran is from February 15, 2022, to September 24, 2025, with a lead plaintiff deadline of January 12, 2026 [2]. - Allegations include failure to ensure safety at the Grasberg Block Cave mine in Indonesia, leading to heightened risks for workers and misleading positive statements about the company's operations [2]. Group 2: Perrigo Company plc (NYSE: PRGO) - The class period for Perrigo is from February 27, 2023, to November 4, 2025, with a lead plaintiff deadline of January 16, 2026 [3]. - The complaint alleges significant underinvestment in the infant formula business acquired from Nestlé, requiring substantial capital expenditures and resulting in overstated financial results [3]. Group 3: StubHub Holdings, Inc. (NYSE: STUB) - The class period for StubHub is from its September 2025 IPO, with a lead plaintiff deadline of January 23, 2026 [4]. - Allegations include misleading statements regarding changes in payment timing to vendors, adversely affecting free cash flow and resulting in materially misleading financial reports [4].

Core Points - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] RCI Hospitality Holdings, Inc. (NASDAQ: RICK) - Class period is from December 15, 2021, to September 16, 2025, with a lead plaintiff deadline of November 20, 2025 [2] - Allegations include materially false and misleading statements regarding tax fraud and bribery, which understated the legal risks and misled investors about the company's business prospects [2] Fortinet, Inc. (NASDAQ: FTNT) - Class period is from November 8, 2024, to August 6, 2025, with a lead plaintiff deadline of November 21, 2025 [3] - Allegations include misleading statements about the refresh cycle of products and the true number of upgradable firewalls, leading to materially misleading representations about the company's operations and prospects [3] Molina Healthcare, Inc. (NYSE: MOH) - Class period is from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025 [4] - Allegations include failure to disclose adverse facts regarding medical cost trend assumptions and the company's financial guidance, which were materially misleading to investors [4] Marex Group plc (NASDAQ: MRX) - Class period is from May 16, 2024, to August 5, 2025, with a lead plaintiff deadline of December 8, 2025 [5] - Allegations include selling over-the-counter financial instruments to itself and inconsistencies in financial statements, leading to materially misleading representations about the company's business and operations [6]

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] Company Summaries Flywire Corporation (NASDAQ: FLYW) - Class Period: February 28, 2024 – February 25, 2025 - Lead Plaintiff Deadline: September 23, 2025 - Allegations include overstating revenue growth sustainability, underestimating the impact of permit and visa restrictions, and misleading positive statements about business operations [2] Lockheed Martin Corporation (NYSE: LMT) - Class Period: January 23, 2024 – July 21, 2025 - Lead Plaintiff Deadline: September 26, 2025 - Allegations include lack of effective internal controls, inaccurate program reviews, overstated contract delivery capabilities, and misleading positive statements about business prospects [3] Sable Offshore Corp. (NYSE: SOC) - Class Period: May 19, 2025 – June 3, 2025 - Lead Plaintiff Deadline: September 26, 2025 - Allegations include false claims about restarting oil production and misleading positive statements regarding business operations [4] Novo Nordisk A/S (NYSE: NVO) - Class Period: May 7, 2025 – July 28, 2025 - Lead Plaintiff Deadline: September 30, 2025 - Allegations include ignoring the significance of personalization exceptions for GLP-1 compounding and misleading statements about the company's ability to capture patient populations [5]

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific allegations of misleading statements and failure to disclose critical information during designated class periods [1]. Company Summaries Hims & Hers Health, Inc. (NYSE: HIMS) - Class Period: April 29, 2025 – June 23, 2025 - Lead Plaintiff Deadline: August 25, 2025 - Allegations include deceptive promotion of illegitimate versions of Wegovy, risking patient safety, and potential termination of collaboration with Novo Nordisk, leading to materially misleading statements about the company's business and prospects [2]. iRobot Corporation (NASDAQ: IRBT) - Class Period: January 29, 2024 – March 11, 2025 - Lead Plaintiff Deadline: September 5, 2025 - Allegations state that iRobot overstated the effectiveness of its Restructuring Plan post-Amazon Acquisition, raising doubts about its ability to operate profitably as a standalone entity, resulting in misleading statements regarding its business and operations [3]. Centene Corporation (NYSE: CNC) - Class Period: December 12, 2024 – June 30, 2025 - Lead Plaintiff Deadline: September 8, 2025 - Allegations indicate that a preliminary analysis revealed lower-than-expected enrollment and increased market morbidity, leading to misleading statements about the company's business and prospects [4].

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific allegations of misleading statements and undisclosed risks during designated class periods [1][2][3][4][5]. Group 1: Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) - Class period is from February 27, 2025, to May 26, 2025, with a lead plaintiff deadline of August 11, 2025 [2]. - Allegations include that Rocket was aware of serious adverse events (SAEs), including participant deaths, and failed to disclose this risk [2]. - The company amended trial protocols without informing shareholders, leading to misleading positive statements about its business and prospects [2]. Group 2: 3D Systems Corporation (NYSE: DDD) - Class period is from August 13, 2024, to May 12, 2025, with a lead plaintiff deadline of August 12, 2025 [3]. - Allegations state that 3D Systems understated the impact of reduced customer spending and overstated its resilience in tough industry conditions [3]. - The updated milestone criteria negatively impacted the company's Regenerative Medicine Program revenue, resulting in misleading statements about its business outlook [3]. Group 3: Tempus AI, Inc. (NASDAQ: TEM) - Class period is from August 6, 2024, to May 27, 2025, with a lead plaintiff deadline of August 12, 2025 [4]. - Allegations include inflation of contract values and risks associated with the joint venture with SoftBank, which appeared to involve "round-tripping" capital [4]. - Concerns were raised about the business model of Tempus-acquired Ambry, which was based on aggressive billing practices, and reduced financial commitments from AstraZeneca [4]. Group 4: Reddit, Inc. (NYSE: RDDT) - Class period is from October 29, 2024, to May 20, 2025, with a lead plaintiff deadline of August 18, 2025 [5]. - Allegations indicate that changes in Google Search algorithms led to decreased traffic to Reddit, which was not disclosed to investors [5]. - The company misrepresented its user rates and advertising revenue outlook, failing to acknowledge the impact of zero-click searches on its traffic [5].